# ServiceNow, Inc.: financial statements, quarterly

NOW · NYSE · CIK 1373715 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/now.md) · [Financials](/companies/now/financials.md) · [Filings](/companies/now/filings.md) · [Insiders](/companies/now/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/now/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,437 d](/filings/0001373715-26-000007.md) | [2,603](/filings/0001373715-25-000126.md) | [2,627](/filings/0001373715-25-000276.md) | [2,797](/filings/0001373715-25-000309.md) | [2,957 d](/filings/0001373715-26-000007.md) | [3,088](/filings/0001373715-26-000056.md) | [3,215](/filings/0001373715-26-000076.md) | [3,407](/filings/0001373715-26-000096.md) | [3,568 d](/filings/0001373715-26-000007.md) | [3,770](/filings/0001373715-26-000056.md) | [3,987](/filings/0001373715-26-000076.md) | [4,106](/filings/0001373715-26-000096.md) |
| Cost of revenue | $m | [516 d](/filings/0001373715-26-000007.md) | [520](/filings/0001373715-25-000126.md) | [552](/filings/0001373715-25-000276.md) | [584](/filings/0001373715-25-000309.md) | [631 d](/filings/0001373715-26-000007.md) | [651](/filings/0001373715-26-000056.md) | [724](/filings/0001373715-26-000076.md) | [774](/filings/0001373715-26-000096.md) | [834 d](/filings/0001373715-26-000007.md) | [940](/filings/0001373715-26-000056.md) | [1,169](/filings/0001373715-26-000076.md) | [1,211](/filings/0001373715-26-000096.md) |
| Gross profit | $m | [1,921 d](/filings/0001373715-26-000007.md) | [2,083](/filings/0001373715-25-000126.md) | [2,075](/filings/0001373715-25-000276.md) | [2,213](/filings/0001373715-25-000309.md) | [2,326 d](/filings/0001373715-26-000007.md) | [2,437](/filings/0001373715-26-000056.md) | [2,491](/filings/0001373715-26-000076.md) | [2,633](/filings/0001373715-26-000096.md) | [2,734 d](/filings/0001373715-26-000007.md) | [2,830](/filings/0001373715-26-000056.md) | [2,818](/filings/0001373715-26-000076.md) | [2,895](/filings/0001373715-26-000096.md) |
| Research and development | $m | [562 d](/filings/0001373715-26-000007.md) | [606](/filings/0001373715-25-000126.md) | [643](/filings/0001373715-25-000276.md) | [626](/filings/0001373715-25-000309.md) | [668 d](/filings/0001373715-26-000007.md) | [703](/filings/0001373715-26-000056.md) | [734](/filings/0001373715-26-000076.md) | [750](/filings/0001373715-26-000096.md) | [773 d](/filings/0001373715-26-000007.md) | [823](/filings/0001373715-26-000056.md) | [915](/filings/0001373715-26-000076.md) | [956](/filings/0001373715-26-000096.md) |
| Operating income | $m | [270 d](/filings/0001373715-26-000007.md) | [332](/filings/0001373715-25-000126.md) | [240](/filings/0001373715-25-000276.md) | [418](/filings/0001373715-25-000309.md) | [374 d](/filings/0001373715-26-000007.md) | [451](/filings/0001373715-26-000056.md) | [358](/filings/0001373715-26-000076.md) | [572](/filings/0001373715-26-000096.md) | [443 d](/filings/0001373715-26-000007.md) | [503](/filings/0001373715-26-000056.md) | [162](/filings/0001373715-26-000076.md) | [385](/filings/0001373715-26-000096.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [6.0](/filings/0001373715-26-000096.md) | not reported | not reported | not reported | [81.0](/filings/0001373715-26-000096.md) |
| Income tax | $m | [52.0 d](/filings/0001373715-26-000007.md) | [78.0](/filings/0001373715-25-000126.md) | [72.0](/filings/0001373715-25-000276.md) | [84.0](/filings/0001373715-25-000309.md) | [79.0 d](/filings/0001373715-26-000007.md) | [95.0](/filings/0001373715-26-000056.md) | [86.0](/filings/0001373715-26-000076.md) | [192](/filings/0001373715-26-000096.md) | [140 d](/filings/0001373715-26-000007.md) | [204](/filings/0001373715-26-000056.md) | [140](/filings/0001373715-26-000076.md) | [93.0](/filings/0001373715-26-000096.md) |
| Net income | $m | [295 d](/filings/0001373715-26-000007.md) | [347](/filings/0001373715-25-000126.md) | [262](/filings/0001373715-25-000276.md) | [432](/filings/0001373715-25-000309.md) | [384 d](/filings/0001373715-26-000007.md) | [460](/filings/0001373715-26-000056.md) | [385](/filings/0001373715-26-000076.md) | [502](/filings/0001373715-26-000096.md) | [401 d](/filings/0001373715-26-000007.md) | [469](/filings/0001373715-26-000056.md) | [298](/filings/0001373715-26-000076.md) | [277](/filings/0001373715-26-000096.md) |
| Diluted EPS | $ per share | not reported | [1.67](/filings/0001373715-25-000126.md) | [1.26](/filings/0001373715-25-000276.md) | [2.07](/filings/0001373715-25-000309.md) | not reported | [0.44](/filings/0001373715-26-000056.md) | [0.37](/filings/0001373715-26-000076.md) | [0.48](/filings/0001373715-26-000096.md) | not reported | [0.45](/filings/0001373715-26-000056.md) | [0.29](/filings/0001373715-26-000076.md) | [0.27](/filings/0001373715-26-000096.md) |
| Basic EPS | $ per share | not reported | [1.69](/filings/0001373715-25-000126.md) | [1.27](/filings/0001373715-25-000276.md) | [2.09](/filings/0001373715-25-000309.md) | not reported | [0.44](/filings/0001373715-26-000056.md) | [0.37](/filings/0001373715-26-000076.md) | [0.48](/filings/0001373715-26-000096.md) | not reported | [0.45](/filings/0001373715-26-000056.md) | [0.29](/filings/0001373715-26-000076.md) | [0.27](/filings/0001373715-26-000096.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.9](/filings/0001373715-26-000007.md) | [2.1](/filings/0001373715-25-000126.md) | [2.2](/filings/0001373715-25-000276.md) | [1.9](/filings/0001373715-25-000309.md) | [2.3](/filings/0001373715-26-000007.md) | [3.4](/filings/0001373715-26-000056.md) | [3.1](/filings/0001373715-26-000076.md) | [2.7](/filings/0001373715-26-000096.md) | [3.7](/filings/0001373715-26-000096.md) | [2.7](/filings/0001373715-26-000056.md) | [2.5](/filings/0001373715-26-000076.md) | [2.4](/filings/0001373715-26-000096.md) |
| Current assets | $bn | [7.8](/filings/0001373715-25-000010.md) | [7.4](/filings/0001373715-24-000169.md) | [8.0](/filings/0001373715-24-000272.md) | [7.7](/filings/0001373715-24-000344.md) | [9.2](/filings/0001373715-26-000007.md) | [9.3](/filings/0001373715-25-000126.md) | [9.3](/filings/0001373715-25-000276.md) | [8.4](/filings/0001373715-25-000309.md) | [10.5](/filings/0001373715-26-000096.md) | [8.4](/filings/0001373715-26-000056.md) | [8.5](/filings/0001373715-26-000076.md) | [8.5](/filings/0001373715-26-000096.md) |
| Total assets | $bn | [17.4](/filings/0001373715-25-000010.md) | [17.5](/filings/0001373715-24-000169.md) | [18.2](/filings/0001373715-24-000272.md) | [18.4](/filings/0001373715-24-000344.md) | [20.4](/filings/0001373715-26-000007.md) | [21.0](/filings/0001373715-25-000126.md) | [22.1](/filings/0001373715-25-000276.md) | [21.8](/filings/0001373715-25-000309.md) | [26.0](/filings/0001373715-26-000096.md) | [24.4](/filings/0001373715-26-000056.md) | [31.7](/filings/0001373715-26-000076.md) | [31.8](/filings/0001373715-26-000096.md) |
| Current liabilities | $bn | [7.4](/filings/0001373715-25-000010.md) | [7.0](/filings/0001373715-24-000169.md) | [7.2](/filings/0001373715-24-000272.md) | [6.8](/filings/0001373715-24-000344.md) | [8.4](/filings/0001373715-26-000007.md) | [8.3](/filings/0001373715-25-000126.md) | [8.5](/filings/0001373715-25-000276.md) | [7.9](/filings/0001373715-25-000309.md) | [10.4](/filings/0001373715-26-000096.md) | [10.0](/filings/0001373715-26-000056.md) | [12.2](/filings/0001373715-26-000076.md) | [11.8](/filings/0001373715-26-000096.md) |
| Total liabilities | $bn | [9.8](/filings/0001373715-25-000010.md) | [9.4](/filings/0001373715-24-000169.md) | [9.5](/filings/0001373715-24-000272.md) | [9.1](/filings/0001373715-24-000344.md) | [10.8](/filings/0001373715-26-000007.md) | [10.8](/filings/0001373715-25-000126.md) | [11.1](/filings/0001373715-25-000276.md) | [10.5](/filings/0001373715-25-000309.md) | [13.1](/filings/0001373715-26-000096.md) | [12.7](/filings/0001373715-26-000056.md) | [19.2](/filings/0001373715-26-000076.md) | [18.7](/filings/0001373715-26-000096.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.5](/filings/0001373715-26-000096.md) | not reported | [5.4](/filings/0001373715-26-000076.md) | [5.4](/filings/0001373715-26-000096.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001373715-26-000096.md) | not reported | [2.1](/filings/0001373715-26-000076.md) | [2.1](/filings/0001373715-26-000096.md) |
| Shareholders' equity | $bn | [7.6](/filings/0001373715-26-000007.md) | [8.1](/filings/0001373715-25-000276.md) | [8.7](/filings/0001373715-25-000309.md) | [9.3](/filings/0001373715-25-000309.md) | [9.6](/filings/0001373715-26-000096.md) | [10.1](/filings/0001373715-26-000076.md) | [10.9](/filings/0001373715-26-000096.md) | [11.3](/filings/0001373715-26-000096.md) | [13.0](/filings/0001373715-26-000096.md) | [11.7](/filings/0001373715-26-000076.md) | [12.5](/filings/0001373715-26-000096.md) | [13.1](/filings/0001373715-26-000096.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,605 d](/filings/0001373715-26-000007.md) | [1,341](/filings/0001373715-25-000126.md) | [620 d](/filings/0001373715-25-000276.md) | [671 d](/filings/0001373715-25-000309.md) | [1,635 d](/filings/0001373715-26-000007.md) | [1,677](/filings/0001373715-26-000056.md) | [716 d](/filings/0001373715-26-000076.md) | [813 d](/filings/0001373715-26-000096.md) | [2,238 d](/filings/0001373715-26-000007.md) | [1,670](/filings/0001373715-26-000056.md) | [587 d](/filings/0001373715-26-000076.md) | [839 d](/filings/0001373715-26-000096.md) |
| Capital expenditure | $m | [261 d](/filings/0001373715-26-000007.md) | [135](/filings/0001373715-25-000126.md) | [262 d](/filings/0001373715-25-000276.md) | [202 d](/filings/0001373715-25-000309.md) | [253 d](/filings/0001373715-26-000007.md) | [205](/filings/0001373715-26-000056.md) | [190 d](/filings/0001373715-26-000076.md) | [235 d](/filings/0001373715-26-000096.md) | [238 d](/filings/0001373715-26-000007.md) | [141](/filings/0001373715-26-000056.md) | [114 d](/filings/0001373715-26-000076.md) | [91.0 d](/filings/0001373715-26-000096.md) |
| Share repurchases | $m | [256 d](/filings/0001373715-26-000007.md) | [175](/filings/0001373715-25-000126.md) | [0.0 d](/filings/0001373715-25-000276.md) | [225 d](/filings/0001373715-25-000309.md) | [296 d](/filings/0001373715-26-000007.md) | [298](/filings/0001373715-26-000056.md) | [361 d](/filings/0001373715-26-000076.md) | [584 d](/filings/0001373715-26-000096.md) | [597 d](/filings/0001373715-26-000007.md) | [2,225](/filings/0001373715-26-000056.md) | [0.0 d](/filings/0001373715-26-000076.md) | [0.0 d](/filings/0001373715-26-000096.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [204](/filings/0001373715-24-000169.md) | [205](/filings/0001373715-24-000272.md) | [206](/filings/0001373715-24-000344.md) | [208](/filings/0001373715-25-000126.md) | [208](/filings/0001373715-25-000276.md) | [209](/filings/0001373715-25-000309.md) | [1,047](/filings/0001373715-26-000056.md) | [1,047](/filings/0001373715-26-000076.md) | [1,048](/filings/0001373715-26-000096.md) | [1,040](/filings/0001373715-26-000056.md) | [1,034](/filings/0001373715-26-000076.md) | [1,043](/filings/0001373715-26-000096.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,038,000,000 at 2026-09-30, from the cover of the [10-Q filed 2026-10-28](/filings/0001373715-26-000096.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 04:38 ET. No prices; not investment advice.